Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
(AMEX: IDXG) Delayed: 1.60 -0.05 (3.03%)
Previous Close $1.65    52 Week High $0.64 
Open $1.65    52 Week Low $0.10 
Day High $1.65    P/E N/A 
Day Low $1.60    EPS $0.00 
Volume 4,644       

(NASDAQ: VYNT) Delayed: 0.26 --0 (-0%)
Previous Close $0.26    52 Week High $ 
Open $0.89    52 Week Low $ 
Day High $0.26    P/E N/A 
Day Low $0.26    EPS $ 
Volume 44,809